Content

Events
About

E-nose Sniffs Out Rare Lung Disease

Pharma IQ News | 09/13/2016
A new technology referred to as an artificial nose has the ability to detect a rare progressive lung disease from a patient’s breath. The enose, produced by Université Paris-Saclay in partnership with the Technion Israel Institute of Technology, is tuned to detect Pulmonary Arterial Hypertension (PAH)- a form of high blood pressure. The disease is known to change the make-up of an individual’s breath.Those suffering from PAH tend to be given a five year life expectancy from diagnosis. The c... To continue reading this story Click Here

Upcoming Events


Pharmaceutical Launch Excellence Summit US

September 30 - October 1, 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now | View Agenda | Learn More


Pharmaceutical Launch Excellence Summit

1 - 3 December, 2026
Novotel Amsterdam City, Netherlands
Register Now | View Agenda | Learn More


SmartLab Exchange Europe

22 - 23 February 2027
Leonardo Royal Hotel Amsterdam, Netherlands
Register Now | View Agenda | Learn More

MORE EVENTS